Cellectar Biosciences, Inc. (CLRB)
3.13
+0.04
(+1.29%)
USD |
NASDAQ |
May 18, 14:53
Cellectar Biosciences Total Assets (Quarterly) : 11.12M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | 131.42M |
| Ocugen, Inc. | 56.90M |
| Invivyd, Inc. | 241.74M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.403M |
| Shareholders Equity (Quarterly) | 4.717M |
| Debt to Equity Ratio | 0.3241 |
| Current Ratio | 1.901 |
| Net Debt Paydown Yield | -1.92% |